Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice
Citations Over TimeTop 1% of 2000 papers
Abstract
Huntington's disease (HD) is caused by an expanded N-terminal glutamine tract that endows huntingtin with a striatal-selective structural property ultimately toxic to medium spiny neurons. In precise genetic models of juvenile HD, HdhQ92 and HdhQ111 knock-in mice, long polyglutamine segments change huntingtin's physical properties, producing HD-like in vivo correlates in the striatum, including nuclear localization of a version of the full-length protein predominant in medium spiny neurons, and subsequent formation of N-terminal inclusions and insoluble aggregate. These changes show glutamine length dependence and dominant inheritance with recruitment of wild-type protein, critical features of the altered HD property that strongly implicate them in the HD disease process and that suggest alternative pathogenic scenarios: the effect of the glutamine tract may act by altering interaction with a critical cellular constituent or by depleting a form of huntingtin essential to medium spiny striatal neurons.
Related Papers
- → Huntingtin–protein interactions and the pathogenesis of Huntington's disease(2004)540 cited
- → Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion(1997)522 cited
- → Huntington's disease: from pathology and genetics to potential therapies(2008)406 cited
- Huntingtin and Huntington’s Disease(2006)
- → Three‐dimensional maps of full‐length huntingtin and linkage to development of Huntington's disease(2016)